Excretion of thromboxane metabolites in healthy women after cessation of smoking.
Cigarette smokers, but not former smokers, excrete more thromboxane A2 (TxA2) metabolites in the urine than do lifelong nonsmokers, which suggests chronic activation of their platelets. To further characterize the effect elicited by smoking on platelet function, we followed the change in urinary excretion of the 2,3-dinor (Tx-M) and 11-dehydro (dTx) metabolites of TxA2, analyzed by gas chromatography/mass spectrometry and radioimmunoassay, respectively, in eight healthy women who quit habitual smoking and compared it with the recovery of these metabolites after a single dose of acetylsalicylic acid (ASA). Tx-M and dTx before cessation of smoking were approximately 550 and 600 pg/mg creatinine, respectively. Within 3 days after quitting smoking, Tx-M and dTx had dropped to stable levels of approximately 300 and 350 pg/mg, respectively. The rates of change in excretion of Tx-M and dTx after smoking cessation were more rapid (p < 0.02 and 0.02, respectively) than those observed during the recovery of platelet function after a single dose of ASA. The excretion of 2,3-dinor-6-keto-prostaglandin F1 alpha, a metabolite of prostacyclin, was not affected by smoking cessation. We conclude that cigarette smoking elicits an increase in platelet activity in the absence of vascular injury. This increase is reversible within the life span of the platelets.
Rångemark
C
C
Department of Clinical Physiology, Gothenburg University, Sweden.
Ciabattoni
G
G
Wennmalm
A
A
D000284:Administration, Oral; D000328:Adult; D001241:Aspirin / Q000008:administration & dosage; D003367:Cotinine / Q000097:blood; D003404:Creatinine / Q000652:urine; D005260:Female; D006801:Humans; D008875:Middle Aged; D012907:Smoking / Q000652:urine; D016540:Smoking Cessation; D013928:Thromboxane A2 / Q000652:urine; D013931:Thromboxanes / Q000378:metabolism* / Q000652:urine*
D013931:Thromboxanes; D013928:Thromboxane A2; D003404:Creatinine; D003367:Cotinine; D001241:Aspirin